skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello Peter and team, I'd like to purchase some high quality US companies whose share prices have been unduly hit by the COVID correction. However, I want to do this in a conservative way - with larger, stable companies with low debt and strong balance sheets; assured 'survivors'. Can you please suggest 5 good US candidates in the 'survive and recover' blue chip camp, and a dividend of at least 2.5 percent. Thanks!
Read Answer Asked by James on May 12, 2020
Q: Thank you for your comments on RPD earnings report yesterday. In your response you said "We would not be overly concerned here, though it has slipped some spots on our list of growth companies". Can you let me know what growth companies you have higher up on your list. I am up 20% on RPD and am happy to sell it for something higher up on your list.

Thanks so much for your excellent service.
Read Answer Asked by Justin on May 12, 2020
Q: Hi 5i team,

There hasn’t been a question on TER since last year. I have held it in the past. It beat on EPS and revenues the last Q but gave wide guidance for the 2nd Q which is almost the same as pulling guidance. It is into testing and automation systems for industrial applications and 5G, as well as robotics which could potentially be a growth area. Your database classifies it as technology, where I really have plenty, but I view it more as industrial. Is it a decent investment for industrial or is there a better option?

Thanks for the insight.
Dave
Read Answer Asked by Dave on May 11, 2020
Q: Which companies you think are leading in quantum computing technology.
Read Answer Asked by Vinod on May 11, 2020
Q: These companies have been doing well lately. When I googled them, each of them all claimed are a cloud communications platform as a service company. I couldn't figure out any differences between them if there are. Could you please help me to understand them? If I pick one to invest, from growth potential perspective, which one you would suggest? From risk/reward perspective, which one do you pick?

Many thinks as always
Read Answer Asked by Lin on May 11, 2020
Q: Hello Peter & Team,

Everyone is starting to focus on how to re-open the economy and what it might look like. All Elective Surgeries were cancelled as well all know, and as a result there is an estimated 30,000 patients who have had their surgery put on hold. Catching up on the back-log is going to take a number of years.

The private sector is going to be heavily leaned to help with this catch-up. Do you have any idea which companies and/or sector(s) might benefit from this in the coming years?

Thanks for all you do

gm
Read Answer Asked by Gord on May 11, 2020
Q: Correct me if I am wrong, the above mentioned names operate in the same space. If so, which one would you suggest I add to my portfolio at this time. Or would you suggest positions in more than one.
Regards
Read Answer Asked by Rajiv on May 08, 2020
Q: The only similarity in these two is that they both focus on cancer. Would 5i advise for or against a new position in either one? I understand that CALA is more speculative and in trials while SGEN is more established. More than happy to take on risk with either position if initiating. Your thoughts on why each are a buy or not?
Read Answer Asked by Tim on May 08, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!